“百亿级”基金业绩回暖，机构：市场有望迎来可持续的“慢牛”

Core Viewpoint - The equity market shows significant signs of recovery, with the Shanghai Composite Index surpassing 3700 points, and several "billion-level" active equity funds achieving performance rebounds in 2023 [1][9] Group 1: Fund Performance - As of mid-2025, there are 22 "billion-level" active equity funds, most of which have achieved positive returns by August 15, 2023 [3] - Notable performers include Penghua Carbon Neutral Theme A and Yongying Advanced Manufacturing Select A, with year-to-date returns of 73.46% and 65.27% respectively [3][4] - Other funds such as ICBC Frontier Medical A and Ruiyuan Growth Value A have returns exceeding 30%, while funds like Xingquan He Yi A and China Europe Medical Health A have returns over 20% [3][4] Group 2: Market Outlook - Multiple public funds express optimism about the market entering a phase of increased activity, driven by a continuous positive cycle of capital [1][9] - Factors such as policy support, expectations of liquidity easing, and ongoing industrial upgrades are expected to lead the A-share market into a more resilient and sustainable "slow bull" phase [1][11] - The market sentiment is currently high, with significant capital inflows from various investor types, including retail and institutional investors [9] Group 3: Sector Focus - The successful funds have strategically invested in popular sectors such as pharmaceuticals and technology [7] - ICBC Frontier Medical A has notably over-allocated to the innovative drug sector, benefiting from the rapid development of domestic innovative drug companies [7] - Ruiyuan Growth Value A has seen significant contributions from investments in Hong Kong stocks and PCB stocks, indicating a diversified approach to sector allocation [7]